NovaMed Announces $125 Million Credit Facility.

CHICAGO -- NovaMed, Inc. (Nasdaq: NOVA) today announced that it has entered into an amendment to its credit facility that increases the size of the facility from $80 million to $125 million and extends the term to February 5, 2010. The amended credit facility also has an option allowing NovaMed to elect to increase the size of the facility to $150 million under certain conditions. National City Bank remains as agent, with LaSalle Bank, Associated Bank, Charter One Bank, Bank of Montreal, The Northern Trust Company and JPMorgan Chase Bank, as the other participating banks. NovaMed intends to use the expanded credit facility for the acquisition and development of ambulatory surgery centers as well as for general corporate purposes.

"NovaMed completed a record number of ambulatory surgery center acquisitions in 2006 and we continue to have a strong acquisition pipeline," said Thomas S. Hall, President and Chief Executive Officer. "Increasing the size of our credit facility at this time will allow us to continue to execute our growth strategy."

NovaMed acquires, develops and operates ambulatory surgery centers in partnership with physicians. NovaMed currently has ownership interests in 37 centers located in 18 states. NovaMed's executive offices are located in Chicago, Illinois.

This press release contains forward-looking statements that relate to possible future events. These statements are based on management's current expectations and are subject to risks and uncertainties, which could cause our actual results to differ materially from those expressed or implied in this press release. These risks and uncertainties relate to our business, our industry and our common stock and include: our ability to acquire, develop or manage a sufficient number of profitable surgical facilities, including facilities that are not exclusively dedicated to eye-related procedures; reduced prices and reimbursement rates for surgical procedures; our ability to access capital on a cost-effective basis to continue to successfully implement our growth strategy; our ability to maintain successful relationships with the physicians who use our surgical facilities; the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit our business operations, require us to incur significant expenditures or limit our ability to relocate our facilities if necessary; and demand for elective surgical procedures. Readers are encouraged to review a more complete discussion of the factors affecting NovaMed's business and prospects in its filings with the Securities and Exchange Commission, including the company's 2005 Form 10-K filed on April 28, 2006. Readers should not place undue reliance on any forward-looking statements. Except as required by the federal securities laws, NovaMed undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.